COX8A and glioblastoma: A limitation of the previously published tools profiled in this study, beyond core performance metrics, is the lack of ability to detect clinically relevant single gene events (Supplementary Table S4), such as the EGFR vIII transcript variant that is a relatively frequent event in glioblastomas (An et al., 2018).